Daré Bioscience, Inc. (DARE) Social Stream
DARE BIOSCIENCE INC (DARE) Price Targets From Analysts
Use the tables below to see what analysts covering DARE BIOSCIENCE INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 24 months, DARE's average price target has gone up $0.6.
Over the past 45 weeks, DARE's average upside potential has been 365.83%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
DARE Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 120 days, DARE's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for DARE as an investment opportunity.
- In terms of how DARE BIOSCIENCE INC fares relative to all US stocks, note that its average analyst price target is greater than 68.45% of that group.
- In the context of all US stocks, DARE BIOSCIENCE INC's upside potential (average analyst target price relative to current price) is greater than 1384.55% of them.
- In the context of all US stocks, DARE BIOSCIENCE INC's variance in analysts' estimates is lower than -1203.34% of them.
- In the context of stocks in the micro market cap category, DARE BIOSCIENCE INC's number of analysts covering the stock is greater than 1252.84% of them.
Stocks similar to DARE BIOSCIENCE INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AGRX, PTN, and HEPA.
View All Top Stocks by Price Target
Is DARE a Buy, Hold or Sell? See the POWR Ratings now!